Vanguard Group Inc Abeona Therapeutics Inc. Transaction History

Vanguard Group Inc

  • $6.44 Trillion
  • Q3 2025

A detailed history of Vanguard Group Inc transactions in Abeona Therapeutics Inc. stock. As of the latest transaction made, Vanguard Group Inc holds 2,602,901 shares of ABEO stock, worth $11.6 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
2,602,901
Previous 2,507,023 3.82%
Holding current value
$11.6 Million
Previous $14.2 Million 3.48%
% of portfolio
0.0%
Previous 0.0%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2025

Nov 07, 2025
BUY
$5.28 - $7.23 $506,235 - $693,197
95,878 Added 3.82%
2,602,901 $13.7 Million
Q2 2025

Aug 11, 2025
BUY
$4.18 - $7.0 $2.03 Million - $3.41 Million
486,838 Added 24.1%
2,507,023 $14.2 Million
Q1 2025

May 09, 2025
BUY
$4.76 - $6.02 $257,811 - $326,055
54,162 Added 2.75%
2,020,185 $9.62 Million
Q4 2024

Feb 11, 2025
SELL
$5.55 - $6.67 $230,896 - $277,492
-41,603 Reduced 2.07%
1,966,023 $10.9 Million
Q3 2024

Nov 13, 2024
BUY
$4.12 - $6.32 $222,995 - $342,070
54,125 Added 2.77%
2,007,626 $12.7 Million
Q2 2024

Aug 13, 2024
BUY
$3.17 - $8.05 $2.7 Million - $6.85 Million
851,543 Added 77.28%
1,953,501 $8.28 Million
Q1 2024

May 10, 2024
BUY
$4.07 - $8.68 $3,365 - $7,178
827 Added 0.08%
1,101,958 $7.99 Million
Q4 2023

Feb 14, 2024
BUY
$3.71 - $5.14 $1.29 Million - $1.79 Million
348,196 Added 46.25%
1,101,131 $5.52 Million
Q3 2023

Nov 14, 2023
BUY
$2.98 - $4.43 $248,329 - $369,160
83,332 Added 12.44%
752,935 $3.17 Million
Q2 2023

Aug 14, 2023
BUY
$2.76 - $5.27 $583,083 - $1.11 Million
211,262 Added 46.09%
669,603 $2.7 Million
Q1 2023

May 15, 2023
BUY
$2.25 - $3.27 $373,074 - $542,201
165,811 Added 56.68%
458,341 $1.29 Million
Q4 2022

Feb 10, 2023
BUY
$2.4 - $5.65 $201 - $474
84 Added 0.03%
292,530 $900,000
Q3 2022

Nov 14, 2022
BUY
$2.79 - $5.56 $815,924 - $1.63 Million
292,446 New
292,446 $889,000

Others Institutions Holding ABEO

# of Institutions
108
Shares Held
32.9M
Call Options Held
1.34M
Put Options Held
271K
View Full List

About ABEONA THERAPEUTICS INC.

ABEO Quotes by TradingView
  • Ticker ABEO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 5,950,380
  • Market Cap $26.5M
  • Description
  • Abeona Therapeutics Inc., a clinical-stage biopharmaceutical company, develops gene and cell therapies for life-threatening rare genetic diseases. Its lead program is EB-101, an autologous, gene-corrected cell therapy that is in Phase III clinical trial for recessive dystrophic epidermolysis bullosa. The company also develops ABO-102, an adeno-a...
More about ABEO
Track This Portfolio

Track Vanguard Group Inc Portfolio

Follow Vanguard Group Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Vanguard Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Vanguard Group Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email